Skip to content

About Us
Solutions
- - - Industry Solutions
      
      Strategic and Scientific Consultancy
      
      Integrated Product Development
      
      Innovations to Market
      
      Optimal Patient Access
      
      Business and Portfolio Mergers & Acquisitions
      
      Industry Sectors
      
      Biotech
      
      Pharmaceutical & Consumer Health
      
      MedTech
      
      Departments
      
      Services
      
      Research and Development
      
      Statistics and Data Science
      
      Market Access
      
      Patient Safety (Pharmacovigilance)
      
      Regulatory Affairs and CMC
      
      Quality Management and Compliance
      
      Training
      
      Research and Development
      
      Statistics and Data Science
      
      Market Access
      
      Patient Safety (Pharmacovigilance)
      
      Regulatory Affairs and CMC
      
      Quality Management and Compliance
Solutions
Insights
- - - News & Events
      - Events
      - Company News
  - - Thought Leadership
  - - Easing the Pathway for Combination Products: An Australian Regulatory Perspective
      
      Journal Article
      
      28th November 2024
      
      Advanced aseptic filling technology and Annex I compliance
      
      Blog & Article
      
      25th November 2024
      
      Commercialization Readiness
      
      Podcast
      
      6th November 2024
      
      13m
      
      What the JCA means for market access in Finland?
      
      Video
Insights
- News & Events
  - Events
  - Company News
- Thought Leadership
Digital Innovation
Careers
Contact Us
Global Reach

Blog & Articles related to GxP Technical Consulting

Blog & Article

The final revision to Annex 1 “Manufacture of Sterile Medicinal Products”

26th August 2022

Blog & Article

Considerations for a value-added internal audit program

28th July 2022

Blog & Article

Key Takeaways from the PDA Europe Annex 1 Workshop

7th June 2022

Quality Documentation

Blog & Article

Is quality documentation an asset or a burden in regulatory affairs?

6th April 2022

Blog & Article

Minimizing risk during the transport of medicinal products

21st March 2022

Blog & Article

Virtual Audits: To be, or not to be, that is the question

26th January 2022

inspection readiness

Blog & Article

How to achieve inspection readiness

18th October 2021

Digital Technology Pharma

Blog & Article

Navigating the complexities of a contamination control program

8th April 2021

compliance pharma

Blog & Article

GET SMART: reliable analytical results & continuous regulatory compliance!

30th March 2021

Blog & Article

Covid19 -Impact on Compliance and Quality Culture

22nd September 2020

Blog & Article

Sterility Assurance for pharmaceuticals

4th August 2020

quality system virtual audits

Blog & Article

Auditing during Covid-19 pandemic – How do we keep on track?

15th April 2020

« Previous Page1 Page2 Page3 Page4 Next »

Company

About Us
Corporate Social Responsibility
Sustainability
Management Team
Sectors

About Us
Corporate Social Responsibility
Sustainability
Management Team
Sectors

Useful links

Contact Us
Imprint
Data Protection
Terms and Conditions
UK Modern Slavery Act Statement

Contact Us
Imprint
Data Protection
Terms and Conditions
UK Modern Slavery Act Statement

Solutions

Strategic and Scientific Consultancy
Integrated Product Development
Innovations to Market
Optimal Patient Access
Business and Portfolio Mergers & Acquisitions

Strategic and Scientific Consultancy
Integrated Product Development
Innovations to Market
Optimal Patient Access
Business and Portfolio Mergers & Acquisitions

Newsletter Sign Up

©2024 PHARMALEX GMBH. ALL RIGHTS RESERVED.

Linkedin-in Youtube

Start typing and press enter to search

Search...

Scroll to Top